Skip to main content

Featured

FS visits biomedical firm in UK

Financial Secretary Paul Chan yesterday visited a biopharmaceutical company and the Royal College of Art, and attended a lunch hosted by the China-Britain Business Council, as part of his ongoing trip to London.   Mr Chan visited AstraZeneca and met the company’s senior management to learn about its drug research and development activities, as well as its latest expansion plans.   AstraZeneca indicated that following in-depth talks with Hong Kong’s Office for Attracting Strategic Enterprises, it plans to develop a research and development centre in Hong Kong and will engage in further discussion with relevant government departments on the matter.   The Financial Secretary then attended a roundtable luncheon held by the China-Britain Business Council, and met representatives of British enterprises that do business, or plan to do business, either in the Mainland or Hong Kong.   Mr Chan later visited the Royal College of Art, which collaborated with the Hong Kong Polytechnic Unive

BioNTech vaccination suspended

The Government today announced that it immediately suspended COVID-19 vaccinations concerning BioNTech after deviations in the vial seal were found in one batch of the vaccine.   It explained that it received written notification this morning from Fosun Industrial Co. about the deviations that involve batch 210102.   The Government noted that while BioNTech and Fosun Pharma have no reason to believe there is a risk to product safety, for the sake of prudence, vaccination of the batch concerned should be suspended pending an investigation.   It added that batch 210104 of the BioNTech vaccine should also be put on hold and not be administered as a precautionary measure to ensure vaccine safety.   The Government stated that people who have made appointments to receive BioNTech vaccination from today onwards need not go to the community vaccination centres for vaccination.   The Department of Health will hold an urgent meeting with Fosun Industrial Co. to obtain further details of the incident and discuss follow-up measures.
http://dlvr.it/RwG7j3

Popular Posts